Price
Target price
?
?
-1.600%
-0.15
-1.600%
€9.51
09:55 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
A loss of -1.600% shows a downward development for Integra LifeSciences Holdings Corp.
Our community is currently low on Integra LifeSciences Holdings Corp with 1 Buy predictions and 4 Sell predictions.
A slightly negative potential of -2.17% at a current price of 9.2 € for Integra LifeSciences Holdings Corp is the result of a target price of 9 €.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | -1.600% | -8.500% | -13.679% | -63.400% | -13.679% | -82.571% | -83.056% |
| Bio-Rad Labs Inc. A | -1.130% | -7.052% | -3.916% | -27.607% | -3.916% | -42.466% | -49.634% |
| Neogen Corp. | -1.720% | 4.217% | 40.650% | -22.072% | 40.650% | - | - |
| Icu Medical Inc. | -1.590% | -3.876% | 0.000% | -21.019% | 0.000% | -29.545% | -25.749% |
Comments
Integra LifeSciences (NASDAQ:IART) had its price target lowered by analysts at Citigroup Inc. from $12.00 to $11.00. They now have a "sell" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its price target raised by analysts at JPMorgan Chase & Co. from $12.00 to $13.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences (NASDAQ:IART) had its "sell" rating reaffirmed by analysts at Citigroup Inc..
Show more
Ratings data for IART provided by MarketBeat